Annual Cash & Cash Equivalents
$4.87 M
-$9.21 M-65.40%
December 31, 2023
Summary
- As of February 22, 2025, SCNI annual cash & cash equivalents is $4.87 million, with the most recent change of -$9.21 million (-65.40%) on December 31, 2023.
- During the last 3 years, SCNI annual cash & cash equivalents has risen by +$1.94 million (+66.22%).
- SCNI annual cash & cash equivalents is now -76.73% below its all-time high of $20.93 million, reached on December 1, 2019.
Performance
SCNI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.03 M
-$2.04 M-66.45%
September 1, 2024
Summary
- As of February 22, 2025, SCNI quarterly cash and cash equivalents is $1.03 million, with the most recent change of -$2.04 million (-66.45%) on September 1, 2024.
- Over the past year, SCNI quarterly cash and cash equivalents has dropped by -$3.79 million (-78.62%).
- SCNI quarterly cash and cash equivalents is now -95.26% below its all-time high of $21.78 million, reached on September 1, 2017.
Performance
SCNI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SCNI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.4% | -78.6% |
| 3 y3 years | +66.2% | -92.7% |
| 5 y5 years | -75.8% | -92.7% |
SCNI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.0% | at low | -94.1% | at low |
| 5 y | 5-year | -76.7% | +66.2% | -95.1% | at low |
| alltime | all time | -76.7% | +97.3% | -95.3% | at low |
Scinai Immunotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.03 M(-66.4%) |
| Jun 2024 | - | $3.08 M(-36.3%) |
| Mar 2024 | - | $4.83 M(-0.9%) |
| Dec 2023 | $4.87 M(-65.4%) | $4.87 M(-23.5%) |
| Sep 2023 | - | $6.36 M(-15.2%) |
| Jun 2023 | - | $7.51 M(-30.5%) |
| Mar 2023 | - | $10.80 M(-23.3%) |
| Dec 2022 | $14.07 M(-19.0%) | $14.07 M(+70.4%) |
| Sep 2022 | - | $8.26 M(-27.4%) |
| Jun 2022 | - | $11.38 M(-26.0%) |
| Mar 2022 | - | $15.37 M(-11.5%) |
| Dec 2021 | $17.37 M(+493.0%) | - |
| Dec 2021 | - | $17.37 M(+61.4%) |
| Sep 2021 | - | $10.77 M(-12.1%) |
| Jun 2021 | - | $12.25 M(-15.8%) |
| Mar 2021 | - | $14.55 M(+396.5%) |
| Dec 2020 | $2.93 M(-86.0%) | $2.93 M(-59.2%) |
| Sep 2020 | - | $7.18 M(-36.1%) |
| Jun 2020 | - | $11.24 M(-46.3%) |
| Dec 2019 | $20.93 M | $20.93 M(-3.1%) |
| Sep 2019 | - | $21.60 M(+127.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $9.49 M(-40.2%) |
| Mar 2019 | - | $15.86 M(-21.3%) |
| Dec 2018 | $20.15 M(-1.9%) | $20.15 M(+37.4%) |
| Sep 2018 | - | $14.67 M(+44.5%) |
| Jun 2018 | - | $10.15 M(-36.0%) |
| Mar 2018 | - | $15.85 M(-22.8%) |
| Dec 2017 | $20.54 M(+403.0%) | $20.54 M(-5.7%) |
| Sep 2017 | - | $21.78 M(+142.5%) |
| Jun 2017 | - | $8.98 M(+35.5%) |
| Mar 2017 | - | $6.63 M(+62.4%) |
| Dec 2016 | $4.08 M(-52.4%) | $4.08 M(+1.6%) |
| Sep 2016 | - | $4.02 M(+2.8%) |
| Jun 2016 | - | $3.91 M(-50.4%) |
| Mar 2016 | - | $7.89 M(-8.0%) |
| Dec 2015 | $8.57 M(+247.3%) | $8.57 M(-7.2%) |
| Sep 2015 | - | $9.24 M(-8.0%) |
| Jun 2015 | - | $10.04 M(+437.2%) |
| Mar 2015 | - | $1.87 M(-24.3%) |
| Dec 2014 | $2.47 M(-51.9%) | $2.47 M(-26.7%) |
| Sep 2014 | - | $3.37 M(-34.3%) |
| Dec 2013 | $5.13 M(+73.8%) | $5.13 M |
| Dec 2012 | $2.95 M | - |
FAQ
- What is Scinai Immunotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual cash & cash equivalents year-on-year change?
- What is Scinai Immunotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Scinai Immunotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SCNI is $4.87 M
What is the all time high annual cash & cash equivalents for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual cash & cash equivalents is $20.93 M
What is Scinai Immunotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SCNI annual cash & cash equivalents has changed by -$9.21 M (-65.40%)
What is Scinai Immunotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SCNI is $1.03 M
What is the all time high quarterly cash and cash equivalents for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly cash and cash equivalents is $21.78 M
What is Scinai Immunotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SCNI quarterly cash and cash equivalents has changed by -$3.79 M (-78.62%)